Advisory Board July 9, 2024

By: Natalie Trebes, Vidal Seegobin, Susan McDonald, and Max Hakanson

The Supreme Court of the United States (SCOTUS) recently overturned the Chevron doctrine, which required courts to defer to federal agencies’ interpretation of ambiguous laws. Advisory Board’s Natalie Trebes, Vidal Seegobin, Susan McDonald, and Max Hakanson explain how this could impact healthcare and highlight what they’ll be watching in the post-Chevron era.

Bold predictions for healthcare in 2024

SCOTUS’ Chevron decision

In a 6-3 decision, SCOTUS overturned the Chevron doctrine on June 28, repealing a 40-year-old legal precedent that required courts to defer to regulatory agencies to interpret ambiguous laws.

Since Chevron v. Natural Resources Defense Council was decided in 1984, it has become one of the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Regulations
What’s Expected to Drive Up Health Plan Costs in 2025: GLP-1s, Behavioral Health, and Inflationary Pressures for Hospitals and Doctors – PwC’s Behind the Numbers 2025
Administration launching multistate licensure compact
A Las Vegas hospital's playbook for presidential care
Policy Innovation Is Outpacing Technology at the Intersection of Health Care and Human Services
Supreme Court Overrules Chevron Doctrine: Ripple Effects Across Health Care

Share This Article